跳至主要内容
临床试验/ISRCTN12374636
ISRCTN12374636进行中(未招募)未知

Evaluating the implementation of targeted pharmacy services to enhance the uptake of SGLT2i among veterans with chronic kidney disease (CKD)

Minneapolis VA Health Care System0 个研究点目标入组 4,000 人开始时间: 2022年3月15日最近更新:
适应症

试验速览

阶段
未知
状态
进行中(未招募)
发起方
入组人数
4,000

研究概览

简要总结

2024 Protocol article in https://doi.org/10.1186/s12882-023-03446-1 (added 08/01/2024)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. CKD (defined as eGFR >=25 and eGFR <60 x2)
  • 2. Type 2 Diabetes (defined as either ICD9/10 code of Type 2 DM or most recent A1c >=7)
  • 3. Must have active Metformin or (not on Metformin and has a Metformin allergy)

排除标准

  • 1. Type 1 diabetes
  • 2. Taking SGLT-2 or GLP-1
  • 3. SGLT2 allergy
  • 4. On dialysis
  • 5. Have a diagnosis of Pancreatic Cancer or Pancreatitis

研究者

发起方
Minneapolis VA Health Care System

相似试验